Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chorionic somatomammotropin hormone 2 (CSH2) is a placental hormone produced exclusively during pregnancy and is a member of the somatotropin/prolactin family of hormones. CSH2 is primarily expressed in the placenta and is involved in stimulating lactation, promoting fetal growth, and modulating maternal and fetal metabolism during gestation. Unlike growth hormone (GH), it does not interact with the growth hormone receptor (GHR) but instead activates the prolactin receptor (PRLR), influencing maternal metabolic adaptation to pregnancy and supporting fetal development. CSH2 shares high sequence identity with related placental lactogens, and differential expression is developmentally regulated. Genetic variants or dysregulation of CSH2 have been associated with gestational trophoblastic diseases, such as choriocarcinoma and epithelioid trophoblastic tumor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chorionic somatomammotropin hormone 2 (CSH2).